Narrative review / 2007
Most antioxidant vitamin trials have failed to reduce cardiovascular morbidity and mortality, with some monotherapies showing potential harm.
Extensive experimental data indicate a central role for oxidative stress in atherogenesis. However, most antioxidant vitamin trials have failed to lower cardiovascular morbidity and mortality, and monotherapy with certain vitamins like vitamin E may be detrimental. The review suggests that more rigorous clinical trial designs and a multifaceted antioxidant approach may be necessary to determine antioxidant utility in cardiovascular disease.
- Study type
- Narrative review
- Who was studied
- Human clinical trials of antioxidant vitamins
- What was measured
- Cardiovascular morbidity and mortality
THE PAPER
Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment?
Thomson MJ, Puntmann V, Kaski JC. Cardiovasc Drugs Ther, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.